Literature DB >> 2432352

Sulfated glycosaminoglycans: a common constituent of all amyloids?

A D Snow, J Willmer, R Kisilevsky.   

Abstract

In the present investigation, we analyzed whether sulfated glycosaminoglycans are a common constituent in many different types of amyloid. Serial sections of amyloidotic tissue were stained for the presence of: (a) amyloid by using Congo Red, and (b) glycosaminoglycans by using both the sodium sulfate Alcian blue method and Alcian blue, pH 5.7, with varying concentrations of magnesium chloride. Our results show that sulfated glycosaminoglycans are always associated anatomically with amyloid deposits regardless of the nature of the protein deposited. Sulfated glycosaminoglycans were found in tissues containing AA, AL, inherited cutaneous amyloid, and senile cardiac amyloid (prealbumin). Additionally, we provide evidence that sulfated glycosaminoglycans are closely associated with the amyloid of medullary carcinoma of the thyroid (prothyrocalcitonin), and neuritic plaques, neurofibrillary tangles, and congophilic angiopathy in Alzheimer's disease. It is postulated that these sulfated glycosaminoglycans can influence the folding of diverse proteins such that all forms of amyloid show a significant beta-pleated sheet component.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432352

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  55 in total

1.  Antibody-mediated resolution of light chain-associated amyloid deposits.

Authors:  R Hrncic; J Wall; D A Wolfenbarger; C L Murphy; M Schell; D T Weiss; A Solomon
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy.

Authors:  G L Zanusso; G Moretto; B Bonetti; S Monaco; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1992-09

3.  Presenilin-1 is associated with Alzheimer's disease amyloid.

Authors:  T Wisniewski; W K Dowjat; B Permanne; J Palha; A Kumar; G Gallo; B Frangione
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

4.  Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.

Authors:  Y Hoshii; H Kawano; D Cui; T Takeda; T Gondo; M Takahashi; K Kogishi; K Higuchi; T Ishihara
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

5.  Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein.

Authors:  Fredrik Noborn; Paul O'Callaghan; Erik Hermansson; Xiao Zhang; John B Ancsin; Ana M Damas; Ingrid Dacklin; Jenny Presto; Jan Johansson; Maria J Saraiva; Erik Lundgren; Robert Kisilevsky; Per Westermark; Jin-Ping Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

Review 6.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

Review 7.  Amyloid-a state in many guises: survival of the fittest fibril fold.

Authors:  Jesper S Pedersen; Daniel E Otzen
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

8.  Electrostatic Complementarity Drives Amyloid/Nucleic Acid Co-Assembly.

Authors:  Allisandra K Rha; Dibyendu Das; Olga Taran; Yonggang Ke; Anil K Mehta; David G Lynn
Journal:  Angew Chem Int Ed Engl       Date:  2019-11-14       Impact factor: 15.336

9.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

Authors:  G A Tennent; L B Lovat; M B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.

Authors:  J Ghiso; E Matsubara; A Koudinov; N H Choi-Miura; M Tomita; T Wisniewski; B Frangione
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.